Target intelligence / Profile preview

Nucleolar protein 4 (NOL4)

Target
NOL4
Molecular classification
Other
01

Overview

Nucleolar protein 4 (NOL4) is a nucleolar-localized protein encoded by the NOL4 gene in humans. It is predicted to enable RNA binding activity and is involved in various cellular processes, primarily within the nucleolus[1][2][5]. NOL4 has been identified as a methylation target in several cancers, including cervical and head and neck cancer, indicating a possible role in tumorigenesis[3]. Though implicated in cancer, it is not established as a classical therapeutic target (such as a receptor, enzyme, or transporter). NOL4 is associated with certain neuroendocrine tumors, but detailed mechanisms and therapeutic targeting remain to be defined[1][3].

Other names
NOLPHRIHFB2255CT125Nucleolar-localized proteinCancer/testis antigen 125nucleolar localized protein
02

Biological functions

RNA bindingNucleolar localizationCellular process involvement
03

Disease associations

Cancer (notably breast large cell neuroendocrine carcinoma, prostate small cell carcinoma, cervical cancer, head and neck cancer)
04

Biomarkers

Aberrant methylation (biomarker in cervical and head/neck cancer)

Beyond the preview

Go deeper on Nucleolar protein 4 (NOL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolar protein 4 (NOL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call